GBG Research at ESMO-BC 2023
05.05.2023
GBG Research at ESMO-Breast Cancer Conference 2023 in Berlin
ICE-Trial (GBG-32)
“Updated long-term overall survival of older adjuvant ibandronate-treated patients with intermediate- or high-risk early breast cancer compared with additional adjuvant capecitabine treatment – The ICE Randomized Clinical Trial”
Marcus Schmidt et al
GAIN-Trial (GBG-33)
“Impact of TROP-2 and its cellular localization on prognosis of breast cancer in the GAIN cohort”
Christina Westhoff et al
INSEMA-Trial (GBG-75)
“Deep learning-based whole slide image analysis to predict sentinel node status in the INSEMA cohort”
Frederik Marmé et al
BMBC-Trial (GBG-79)
“Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases: a subanalysis of the German Brain metastases in Breast Cancer registry (BMBC)”
Elena Laakmann et al
All projects will be presented at the poster session, Friday, 12. May 12:15 – 13:00 in the Exhibition area.
News
-
21.09.2023 New review on Immune Cell Infiltration published
A review from the International Immuno-Oncology Biomarker Working about tumor immunology was published in the journal of pathology.
Mehr ... -
07.09.2023 Save the date! GBG Annual Scientific Meeting 2024
Das 21. Annual Scientific Meeting 2024 wird am 29.2. bis 1.3. in Frankfurt stattfinden.
Mehr ... -
11.08.2023 Erste Probandin in der BRCA-P-Studie
In Deutschland wurde die erste Teilnehmerin in die BRCA-P-Studie eingeschlossen.
Mehr ... -
06.07.2023 Studie zu Hirnmetastasen ausgezeichnet
Der 42. Jahreskongress für Senologie zeichnet unsere Studie zu Hirnmetastasen bei Brustkrebs aus.
Mehr ...